Perpetua Medical (Germany) Performance
| P75 Stock | EUR 0.45 0.01 2.27% |
On a scale of 0 to 100, Perpetua Medical holds a performance score of 6. The company holds a Beta of 0.28, which implies not very significant fluctuations relative to the market. As returns on the market increase, Perpetua Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Perpetua Medical is expected to be smaller as well. Please check Perpetua Medical's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to make a quick decision on whether Perpetua Medical's historical price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Perpetua Medical AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Perpetua Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Quick Ratio | 4.63 | |
| Fifty Two Week Low | 0.3640 | |
| Fifty Two Week High | 1.2020 |
Perpetua |
Perpetua Medical Relative Risk vs. Return Landscape
If you would invest 39.00 in Perpetua Medical AB on October 16, 2025 and sell it today you would earn a total of 6.00 from holding Perpetua Medical AB or generate 15.38% return on investment over 90 days. Perpetua Medical AB is currently producing 0.3125% returns and takes up 3.8335% volatility of returns over 90 trading days. Put another way, 34% of traded stocks are less volatile than Perpetua, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Perpetua Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Perpetua Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Perpetua Medical AB, and traders can use it to determine the average amount a Perpetua Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0815
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | P75 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.83 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Perpetua Medical is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Perpetua Medical by adding it to a well-diversified portfolio.
Perpetua Medical Fundamentals Growth
Perpetua Stock prices reflect investors' perceptions of the future prospects and financial health of Perpetua Medical, and Perpetua Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Perpetua Stock performance.
| Return On Equity | -106.29 | |||
| Return On Asset | -34.26 | |||
| Current Valuation | 11.02 M | |||
| Shares Outstanding | 12.72 M | |||
| Debt To Equity | 0.08 % | |||
About Perpetua Medical Performance
By analyzing Perpetua Medical's fundamental ratios, stakeholders can gain valuable insights into Perpetua Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Perpetua Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Perpetua Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Pharmacolog i Uppsala AB develops systems and solutions for use of intravenous drugs in Sweden. The company was founded in 2007 and is based in Uppsala, Sweden. PHARMACOLOG is traded on Frankfurt Stock Exchange in Germany.Things to note about Perpetua Medical performance evaluation
Checking the ongoing alerts about Perpetua Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Perpetua Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Perpetua Medical has some characteristics of a very speculative penny stock | |
| Perpetua Medical had very high historical volatility over the last 90 days | |
| Perpetua Medical has high likelihood to experience some financial distress in the next 2 years | |
| About 44.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Perpetua Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Perpetua Medical's stock is overvalued or undervalued compared to its peers.
- Examining Perpetua Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Perpetua Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Perpetua Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Perpetua Medical's stock. These opinions can provide insight into Perpetua Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Perpetua Stock analysis
When running Perpetua Medical's price analysis, check to measure Perpetua Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perpetua Medical is operating at the current time. Most of Perpetua Medical's value examination focuses on studying past and present price action to predict the probability of Perpetua Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perpetua Medical's price. Additionally, you may evaluate how the addition of Perpetua Medical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |